🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Approximately one-third of patients treated on TT 2 protocol and half of those treated on TT 3A protocol were alive at 15 to 20 years post-diagnosis. ja.ma/43uAn1m

Check our long term follow up of earlier total therapy protocols in Arkansas JAMA Oncology UAMS Myeloma Center #mmsm ➡️ jamanetwork.com/journals/jamao… ✅ With time limited therapy&median follow up of ~17 years of 1202 patients, we estimate one out of three patients are cured from their multiple

Half of the patients treated with the TT3A protocol survived for 20 years, a powerful testament to Dr. Barlogie's legacy in the pursuit of a CURE for myeloma. jamanetwork.com/journals/jamao…

Just arrived in Milan 🇮🇹 Excited to participate in the IMWG summit #mmsm – honored to be part of such an amazing group of myeloma researchers UAMS Myeloma Center International Myeloma Foundation

Vincent Rajkumar Al-Ola A Abdallah MD (USMIRC) Rahul Banerjee, MD, FACP 4/ Samer Al Hadidi, MD,MS,FACP on a long term follow up of earlier total therapy protocols: x.com/HadidiSamer/st…

#mmsm #IMWG25 NEJM Nice figure Francesco Maura indicating that there is a group of SMM who has immune containment brake system that prevent progression into MM where early intervention may not be appropriate

#mmsm #IMWG25 Nice publication shared by Thanos Dimopoulos Blood Advances n=427 patients after 2014 with patterns of disease progression ➡️low risks of complications when modern criteria for diagnosis and risk stratification are used. ➡️ashpublications.org/bloodadvances/…

#mmsm Journal of Clinical Oncology New definition of high risk multiple myeloma by IMWG ➡️ascopubs.org/doi/10.1200/JC… Summary 👇

#mmsm #IMWG25 Journal of Clinical Oncology The rationale of having a cut off 20% or higher for del17p or any TP53 as a high risk criteria for multiple myeloma There were variable thresholds used before to define what is a significant level of del17p

#mmsm #IMWG25 New response criteria changes - Getting rid of sCR and keeping CR (more focus on mass spec) - Detailed imaging response criteria based on RAC score (MRI) and Deauville score (PET) - 24-hr UPEP at baseline at confirmation of CR (not frequent) - defining cure in

#mmsm #IMWG25 Projected PFS in using Quad therapy in both transplant eligible and in-eligible 👇

x.com/HadidiSamer/st…

#mmsm #IMWG25 Summer of the CARTITUDE programs for Cilta Cel

#mmsm #IMWG25 combination therapy of GPRC5D BsAb summary table

#mmsm #IMWG25 nizar jacques bahlis nice summary on BsAb vs CAR-T on T cell effect and dependencies

#mmsm #IMWG25 Nice summary on why we need novel constructs and novel stratifies for T cell engaging therapy

#mmsm #IMWG25 Summary of resistance mechanisms to immunotherapy Ajai Chari

Presentation from Samer Al Hadidi, MD,MS,FACP at #ASCO25. #uamsmyeloma #uamscancer #WPRCI #uamshealth #mmsm

Excited to Participate in the 16th Annual IMWG Summit - Samer Al Hadidi Samer Al Hadidi, MD,MS,FACP International Myeloma Foundation oncodaily.com/blog/imwg-summ… #Cancer #Oncology #OncoDaily #Health #Medicine CancerWorld